81
Participants
Start Date
December 15, 2021
Primary Completion Date
August 22, 2024
Study Completion Date
August 22, 2024
Bomedemstat
Capsule (oral)
Middlemore Clinical Trials, Papatoetoe
Royal Prince Alfred Hospital, Camperdown
Royal North Shore Hospital, Saint Leonards
Ospedale di Circolo-a Fondazione Macchi, Varese
Gold Coast Hospital and Health Service, Southport
Royal Adelaide Hospital, Adelaide
Azienda Ospedaliera SS. Antonio, Alessandria
UMPC Hillman Cancer Center, Pittsburgh
Azienda Ospedaliero Universitaria di Bologna, Pavia
University of Miami Leonard M. Miller, Miami
Cleveland Clinic Foundation, Cleveland
Universittsklinikum Essen, Essen
University of Michigan, Ann Arbor
Azienda Ospedaliero-Universitaria Careggi - S.O.D. Ematologia (CRIMM), Florence
Fred Hutchinson Cancer Center, Seattle
Queen Mary Hospital, Hong Kong
Waitemata District Health Board, Takapuna
University College London Hospitals NHS Foundation Trust, London
Guy's and Saint Thomas' NHS Foundation Trus, London
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
INDUSTRY